Robert W. Schwenk

2.1k total citations
32 papers, 1.6k citations indexed

About

Robert W. Schwenk is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Robert W. Schwenk has authored 32 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 14 papers in Surgery and 10 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Robert W. Schwenk's work include Metabolism, Diabetes, and Cancer (16 papers), Pancreatic function and diabetes (14 papers) and Cardiovascular Function and Risk Factors (7 papers). Robert W. Schwenk is often cited by papers focused on Metabolism, Diabetes, and Cancer (16 papers), Pancreatic function and diabetes (14 papers) and Cardiovascular Function and Risk Factors (7 papers). Robert W. Schwenk collaborates with scholars based in Netherlands, Germany and Canada. Robert W. Schwenk's co-authors include Jan F. C. Glatz, Joost J.F.P. Luiken, Arend Bonen, Annette Schürmann, Graham P. Holloway, Will A. Coumans, Ellen Dirkx, Heike Vogel, Laura K.M. Steinbusch and Guillaume J.J.M. van Eys and has published in prestigious journals such as Journal of Biological Chemistry, Diabetes and Biochemical Journal.

In The Last Decade

Robert W. Schwenk

31 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert W. Schwenk Netherlands	24	918	465	349	317	317	32	1.6k
Vivian E.H. Dahlmans Netherlands	22	843 0.9×	398 0.9×	411 1.2×	337 1.1×	362 1.1×	34	1.7k
Birgit Knebel Germany	25	838 0.9×	445 1.0×	339 1.0×	223 0.7×	353 1.1×	84	1.7k
Gabriela Orasanu United States	14	822 0.9×	371 0.8×	212 0.6×	220 0.7×	302 1.0×	20	1.6k
Midori Fujishiro Japan	15	706 0.8×	478 1.0×	222 0.6×	206 0.6×	295 0.9×	22	1.5k
Dmitri Samovski United States	16	990 1.1×	498 1.1×	248 0.7×	221 0.7×	181 0.6×	24	1.8k
Tura Ferré Spain	20	639 0.7×	555 1.2×	443 1.3×	141 0.4×	314 1.0×	25	1.4k
Sabina Paglialunga Canada	23	726 0.8×	667 1.4×	185 0.5×	164 0.5×	165 0.5×	50	1.6k
Tomohiro Tanaka Japan	25	801 0.9×	482 1.0×	344 1.0×	187 0.6×	481 1.5×	103	2.2k
Archana Vijayakumar United States	20	980 1.1×	557 1.2×	327 0.9×	206 0.6×	710 2.2×	32	2.1k
Miranda Nabben Netherlands	25	787 0.9×	540 1.2×	191 0.5×	463 1.5×	145 0.5×	55	1.5k

Countries citing papers authored by Robert W. Schwenk

Since Specialization

Citations

This map shows the geographic impact of Robert W. Schwenk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert W. Schwenk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert W. Schwenk more than expected).

Fields of papers citing papers by Robert W. Schwenk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert W. Schwenk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert W. Schwenk. The network helps show where Robert W. Schwenk may publish in the future.

Co-authorship network of co-authors of Robert W. Schwenk

This figure shows the co-authorship network connecting the top 25 collaborators of Robert W. Schwenk. A scholar is included among the top collaborators of Robert W. Schwenk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert W. Schwenk. Robert W. Schwenk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Otto, Christoph, Alexandra Friedrich, Ivana Vrhovac, et al.. (2020). Antidiabetic Effects of a Tripeptide That Decreases Abundance of Na⁺-d-glucose Cotransporter SGLT1 in the Brush-Border Membrane of the Small Intestine. ACS Omega. 5(45). 29127–29139. 2 indexed citations

Saussenthaler, Sophie, Markus Jähnert, Wenke Jonas, et al.. (2016). Early hypermethylation of hepaticIgfbp2results in its reduced expression preceding fatty liver in mice. Human Molecular Genetics. 25(12). ddw121–ddw121. 42 indexed citations

Baumeier, Christian, Daniel R. Kaiser, Jörg Heeren, et al.. (2015). Caloric restriction and intermittent fasting alter hepatic lipid droplet proteome and diacylglycerol species and prevent diabetes in NZO mice. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1851(5). 566–576. 91 indexed citations

Streng, Alexander S., Leo Jacobs, Robert W. Schwenk, et al.. (2014). Cardiac troponin in ischemic cardiomyocytes: Intracellular decrease before onset of cell death. Experimental and Molecular Pathology. 96(3). 339–345. 29 indexed citations

Dirkx, Ellen, Guillaume J.J.M. van Eys, Robert W. Schwenk, et al.. (2014). Protein kinase-D1 overexpression prevents lipid-induced cardiac insulin resistance. Journal of Molecular and Cellular Cardiology. 76. 208–217. 33 indexed citations

Schwenk, Robert W., et al.. (2013). Diet-dependent Alterations of Hepatic Scd1 Expression are Accompanied by Differences in Promoter Methylation. Hormone and Metabolic Research. 45(11). 786–794. 44 indexed citations

Glatz, Jan F. C., Yeliz Angın, Laura K.M. Steinbusch, Robert W. Schwenk, & Joost J.F.P. Luiken. (2012). CD36 as a target to prevent cardiac lipotoxicity and insulin resistance. Prostaglandins Leukotrienes and Essential Fatty Acids. 88(1). 71–77. 44 indexed citations

Schwenk, Robert W., Yeliz Angın, Laura K.M. Steinbusch, et al.. (2012). Overexpression of Vesicle-associated Membrane Protein (VAMP) 3, but Not VAMP2, Protects Glucose Transporter (GLUT) 4 Protein Translocation in an in Vitro Model of Cardiac Insulin Resistance. Journal of Biological Chemistry. 287(44). 37530–37539. 41 indexed citations

Dirkx, Ellen, Olivier Cazorla, Robert W. Schwenk, et al.. (2012). Protein kinase D increases maximal Ca²⁺-activated tension of cardiomyocyte contraction by phosphorylation of cMyBP-C-Ser³¹⁵. American Journal of Physiology-Heart and Circulatory Physiology. 303(3). H323–H331. 16 indexed citations

10.

Dirkx, Ellen, Robert W. Schwenk, Jan F. C. Glatz, Joost J.F.P. Luiken, & Guillaume J.J.M. van Eys. (2011). High fat diet induced diabetic cardiomyopathy. Prostaglandins Leukotrienes and Essential Fatty Acids. 85(5). 219–225. 71 indexed citations

11.

Steinbusch, Laura K.M., Wino J. Wijnen, Robert W. Schwenk, et al.. (2010). Differential regulation of cardiac glucose and fatty acid uptake by endosomal pH and actin filaments. American Journal of Physiology-Cell Physiology. 298(6). C1549–C1559. 34 indexed citations

12.

Schwenk, Robert W., Ellen Dirkx, Will A. Coumans, et al.. (2010). Requirement for distinct vesicle-associated membrane proteins in insulin- and AMP-activated protein kinase (AMPK)-induced translocation of GLUT4 and CD36 in cultured cardiomyocytes. Diabetologia. 53(10). 2209–2219. 97 indexed citations

13.

Holloway, Graham P., Robert W. Schwenk, Joost J.F.P. Luiken, Jan F. C. Glatz, & Arend Bonen. (2010). Fatty acid transport in skeletal muscle: role in energy provision and insulin resistance. Clinical Lipidology. 5(5). 731–745. 7 indexed citations

14.

Schwenk, Robert W., Graham P. Holloway, Joost J.F.P. Luiken, Arend Bonen, & Jan F. C. Glatz. (2010). Fatty acid transport across the cell membrane: Regulation by fatty acid transporters. Prostaglandins Leukotrienes and Essential Fatty Acids. 82(4-6). 149–154. 228 indexed citations

15.

Jain, Swati, Adrian Chabowski, Laelie A. Snook, et al.. (2009). Additive effects of insulin and muscle contraction on fatty acid transport and fatty acid transporters, FAT/CD36, FABPpm, FATP1, 4 and 6. FEBS Letters. 583(13). 2294–2300. 75 indexed citations

16.

Schwenk, Robert W., Joost J.F.P. Luiken, Arend Bonen, & Jan F. C. Glatz. (2008). Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease. Cardiovascular Research. 79(2). 249–258. 110 indexed citations

17.

Schwenk, Robert W., Joost J.F.P. Luiken, & Jürgen Eckel. (2007). FIP2 and Rip11 specify Rab11a-mediated cellular distribution of GLUT4 and FAT/CD36 in H9c2-hIR cells. Biochemical and Biophysical Research Communications. 363(1). 119–125. 25 indexed citations

18.

Schwenk, Robert W. & Jürgen Eckel. (2006). A novel method to monitor insulin-stimulated GTP-loading of Rab11a in cardiomyocytes. Cellular Signalling. 19(4). 825–830. 14 indexed citations

19.

Ezenwaka, Chidum E., et al.. (2006). Serum adiponectin levels and enzyme markers of liver dysfunction in diabetic and non-diabetic Caribbean subjects. British Journal of Biomedical Science. 63(3). 117–122. 3 indexed citations

20.

Ezenwaka, Chidum E., et al.. (2005). The E23K variant in the Kir6.2 subunit of the ATP-sensitive K+ channel does not augment impaired glucose tolerance in Caribbean subjects with a family history of type 2 diabetes. Journal of Endocrinology. 185(3). 439–444. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact